Patterns of Anti-Osteoporosis Medication Use among Women at High Risk of Fracture: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)

• Stephen Gehlbach ,

  * E-mail: gehlbach@schoolph.umass.edu

  Affiliation University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Frederick H. Hooven,

  Affiliation University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Allison Wyman,

  Affiliation University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Adolfo Diez-Perez,

  Affiliation Hospital del Mar, Autonomous University of Barcelona, Spain

  ⨯
• Jonathan D. Adachi,

  Affiliation Saint Joseph’s Hospital, McMaster University, Hamilton, Ontario, Canada

  ⨯
• Xuemei Luo,

  Affiliation Pfizer, Groton, Connecticut, United States of America

  ⨯
• Andrew G. Bushmakin,

  Affiliation Pfizer, Groton, Connecticut, United States of America

  ⨯
• Frederick A. Anderson,

  Affiliation University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• for the GLOW Investigators